The novel approach of this peptide represents a major breakthrough in the management of diabetes mellitus type 2. Unlike existing drugs, tirzepatide affects two pathways – the GLP-1 hormone and GIP – resulting in https://tirzepatidepeptide182033.bloginwi.com/75871907/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment